Firefly Neuroscience Files Definitive Proxy Statement

TL;DR

Firefly Neuroscience filed its proxy statement for shareholder voting. Get ready to vote!

AI Summary

Firefly Neuroscience, Inc. filed its definitive proxy statement (DEF 14A) on January 21, 2025, for its fiscal year ending December 31, 2024. The filing concerns information required for its proxy statement, which is used to solicit votes from shareholders for upcoming meetings. The company, formerly known as Wavedancer, Inc. and Information Analysis Inc., is based in Kenmore, NY.

Why It Matters

This filing is crucial for shareholders as it outlines the agenda and proposals for the company's annual meeting, allowing them to make informed voting decisions on corporate matters.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEF 14A) that provides information to shareholders and does not inherently indicate new risks.

Key Numbers

• 20250121 — Filing Date (Date the definitive proxy statement was filed with the SEC.)
• 20250214 — Fiscal Year End (The period for which the proxy statement information is relevant.)

Key Players & Entities

• FIREFLY NEUROSCIENCE, INC. (company) — Registrant
• WAVEDANCER, INC. (company) — Former Company Name
• INFORMATION ANALYSIS INC (company) — Former Company Name
• 1100 MILITARY ROAD, KENMORE, NY 14217 (location) — Business and Mail Address

FAQ

Key Financial Figures

• $0.0001 — and outstanding common stock, par value $0.0001 per share ("common stock"), pursuant to

Filing Documents

• ny20041104x2_def14a.htm (DEF 14A) — 1311KB
• logo_fireflyneuro.jpg (GRAPHIC) — 30KB
• ny20041104x2_pc01.jpg (GRAPHIC) — 607KB
• ny20041104x2_pc02.jpg (GRAPHIC) — 427KB
• 0001140361-25-001438.txt ( ) — 2778KB

From the Filing

DEF 14A 1 ny20041104x2_def14a.htm DEF 14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material Pursuant to 240.14a-12 FIREFLY NEUROSCIENCE, INC. (Name of Registrant as Specified in Its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check all boxes that apply): ☒ No fee required ☐ Fee paid previously with preliminary materials ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. TABLE OF CONTENTS FIREFLY NEUROSCIENCE, INC. 1100 Military Road Kenmore, NY 14217 NOTICE OF SPECIAL MEETING OF STOCKHOLDERS to be held on February 14, 2025 TO THE STOCKHOLDERS OF FIREFLY NEUROSCIENCE, INC.: Dear Stockholder: The board of directors (the "Board") of Firefly Neuroscience, Inc. (the "Company", "we", "us", or "our") is soliciting proxies to be used at a special meeting of stockholders (the "Special Meeting"), which will be held on Friday, February 14, 2025 at 10:00 a.m., Eastern Time. To provide access to our stockholders regardless of geographic location, the Special Meeting will be held in a virtual-only meeting format at www.virtualshareholdermeeting.com/AIFF2025SM. The Special Meeting will be held for the following purposes: (1) To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 20% or more of our issued and outstanding common stock, par value $0.0001 per share ("common stock"), pursuant to the Securities Purchase Agreement (the "Security Purchase Agreement"), dated as of December 20, 2024, between the Company and Helena Special Opportunities LLC ("Helena"), including upon the conversion of a convertible note issued to Helena and upon the exercise of a warrant issued to Helena . (2) To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 20% or more of our issued and outstanding common stock pursuant to the Purchase Agreement (the "Purchase Agreement"), dated December 20, 2024, between the Company and Arena Business Solutions Global SPC II, Ltd ("Arena"). (3) To approve an adjournment of the Special Meeting from time to time, to a later date or dates, if necessary or appropriate, under certain circumstances, including for the purpose of soliciting additional proxies in favor of the foregoing proposal in the event the Company does not receive the requisite stockholder vote to approve such proposal or to establish a quorum. The foregoing items of business are more fully described in the proxy statement accompanying this notice or made available over the Internet. We are not aware of any other business to come before the Special Meeting. Your attention is directed to the attached proxy statement accompanying this Notice for a more complete statement of matters to be considered at the Special Meeting. The Board has fixed the close of business on January 6, 2025 as the record date (the "Record Date") for a determination of stockholders entitled to notice of, and to vote at, the Special Meeting or any adjournment or postponement thereof. Only stockholders of record at the close of business on January 6, 2025 are entitled to notice and to vote at the Special Meeting and any adjournment or postponement thereof. It is important that your shares are represented at the Special Meeting. We urge you to review the attached proxy statement and, whether or not you plan to attend the Special Meeting, please vote your shares promptly by casting your vote via the Internet or any other provided voting option, or, if you receive a full set of proxy materials by mail or request one be mailed to you, and prefer to mail your proxy, please complete, sign, date, and return your proxy in the pre-addressed envelope provided, which requires no additional TABLE OF CONTENTS postage if mailed in the United States. You may revoke your vote by submitting a subsequent vote over the Internet, by mail or by any other option provided for voting before the Special Meeting, or by voting in person at the Special Meeting. If you plan to attend the Special Meeting, please notify us of your intentions. This will assist us with meeting preparations. If your shares are not registered in your own name and you would like to attend the Special Meeting, please follow the instructions contained in the Proxy Materials that has been mailed to you, the a

View Full Filing

View this DEF 14A filing on SEC EDGAR